FDA Inspection
Cantor BioConnect, Inc.Cantor BioConnect, Inc. – FDA Inspection, Mar 24, 2026
Record Details
This FDA Inspection record concerns Cantor BioConnect, Inc., with an inspection on March 24, 2026, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 606f4ba3-5651-413a-b5b8-df5cceefc700
Inspection Facts
- Inspection number
- 1309164
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 600.14(a)(1)Who must report - receiving information
- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cantor BioConnect, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Cantor BioConnect, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.